TABLE 1. Maintenance treatment studies for unipolar disorder
|
|
Length of |
|
|
|
|
Symptom-free |
study |
|
|
|
Study |
interval |
(yr) |
Treatment |
Total N |
Outcomea |
Bjork et al. (11) |
4 months |
1 |
Zimelidine Placebo |
38 |
Z > P |
Coppen et al. (15) |
6 months |
1 |
Amitriptyline Placebo |
29 |
A > P |
Coppen et al. (16) |
Undefined b |
2 |
Lithium Placebo |
26 |
L > P |
Doogan et al. (18) |
Undefined |
1 |
Sertraline Placebo |
295 |
S > P |
Eric et al. (20) |
Undefined |
1 |
Paroxetine Placebo |
125 |
Pa > P |
Frank et al. (23) |
17 weeks |
3 |
Imipramine Placebo |
51 |
I > P |
Georgotis et al. (27) |
4 months |
1 |
Phenelzine Nortriptyline Placebo |
51 |
Ph > P Ph > N N = P |
Glen et al. (28) |
Undefined |
3 |
Lithium Amitriptyline Placebo |
28 |
L = A = P |
Kane et al. (37) |
6 months |
2 |
Lithium Imipramine Placebo |
19 |
L > P L > I I = P |
Montgomery et al. (49) |
18 weeks |
1 |
Fluoxetine Placebo |
220 |
F > P |
OADIG (53) |
8 weeks |
2 |
Diothepin Placebo |
69 |
D > P |
Prien et al. (60) |
Undefined b |
2 |
Lithium Imipramine Placebo |
88 |
L > P I > P L = I |
Prien et al. (62) |
2 months |
2 |
Lithium Imipramine Placebo |
110 |
L > P I > P L > I |
Robinson et al. (65) |
16 weeks |
2 |
Phenelzine Placebo |
47 |
Ph > P |
Rouillan et al. (67) |
Undefined |
1 |
Maprotiline Placebo |
1141 |
M > P |
a Based on p = 0.05 level of
significance.
b Maintenance treatment initiated at discharge from hospital.
published 2000